HB3492, titled the “Protect Children’s Innocence Act,” would amend federal criminal law to create or expand penalties for genital or bodily mutilation and chemical castration of minors. The bill rewrites section 116 of title 18 of the U.S. Code to make it a federal crime, punishable by up to 10 years in prison and/or a fine, to knowingly perform or attempt to perform genital or bodily mutilation on a minor, or to chemically castrate a minor, when the conduct involves interstate or foreign commerce or occurs in federal jurisdiction. It also separately criminalizes facilitating, consenting to, or transporting a minor for female genital mutilation.
The bill defines “genital or bodily mutilation” broadly to include female genital mutilation and a wide range of surgeries and procedures performed to change a person’s body to correspond to a sex different from their biological sex, including certain genital surgeries, chest surgery, facial feminization or masculinization procedures, implants, and related reconstructive procedures. It also defines “chemical castration” to include administering puberty blockers, testosterone, or estrogen when used for those purposes. The bill contains exceptions for medically necessary procedures, certain intersex conditions and disorders, complications from prior procedures, and precocious puberty, and it states that mental, behavioral, or emotional distress is not considered a health justification. It also bars a defense based on religion, custom, tradition, ritual, or standard practice for female genital mutilation cases.
If enacted, the bill would significantly expand federal criminal exposure in this area and would affect physicians, medical providers, parents, and others involved in gender-affirming care or female genital mutilation-related conduct involving minors. It would also amend the chapter 7 table of sections in title 18 to reflect the new section heading. The bill is framed as a federal child-protection measure, but its definitions and scope would likely have broad implications for medical practice and criminal enforcement.
The available vote history suggests the bill was politically divisive but had enough support to pass the House narrowly. The recorded votes show a close passage vote and a failed motion to recommit, indicating substantial opposition even as the bill advanced. The Senate status shows it was received and referred to the Judiciary Committee, with no committee transcript available here to show further debate.
The main points of contention are likely the bill’s broad definition of prohibited conduct, especially its inclusion of gender-affirming surgeries and puberty blockers under “genital or bodily mutilation” and “chemical castration,” versus supporters’ apparent intent to prohibit irreversible procedures on minors. Another likely area of dispute is the bill’s exceptions for intersex conditions and certain medical circumstances, which may be viewed by supporters as necessary safeguards and by opponents as either too narrow or too vague. The bill also appears to raise concerns about federal overreach into medical decision-making and the treatment of transgender minors.
The bill would amend 18 U.S.C. § 116 by replacing the existing female genital mutilation-focused provision with a broader federal offense covering genital or bodily mutilation and chemical castration of minors. It would create new criminal penalties, define covered procedures and terms, and add explicit exceptions and jurisdictional hooks tied to interstate commerce and federal territories. In practical terms, it would affect criminal law, medical providers, and potentially parents or facilitators involved in the covered conduct.
The bill appears to have generated strong partisan and policy division. Its narrow House passage and failed recommittal motion indicate meaningful support but also substantial opposition. The lack of committee transcript material limits direct insight into debate, but the vote pattern suggests the measure was controversial and closely contested.
The central controversy is the bill’s treatment of gender-affirming care for minors, which opponents are likely to view as an attempt to criminalize medically accepted treatment, while supporters likely frame it as protecting children from irreversible harm. A second major point of contention is the breadth of the definitions, including surgeries, implants, facial procedures, and puberty blockers, which could sweep in a wide range of medical practices. There may also be disagreement over the medical exceptions, the exclusion of mental or emotional distress as a health justification, and the bill’s federal reach into matters traditionally regulated by states and medical licensing systems.